Highlights This special article provides updated treatment recommendations on thyroid cancer. New targeted systemic therapies have now been approved for treating patients with advanced/metastatic thyroid cancers. This article summarises these new options and the order in which they should be used. Recommendations are based on available scientific data and the authors’ collective expert opinion. ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer
Papotti, M G;Berruti, A
2022-01-01
Abstract
Highlights This special article provides updated treatment recommendations on thyroid cancer. New targeted systemic therapies have now been approved for treating patients with advanced/metastatic thyroid cancers. This article summarises these new options and the order in which they should be used. Recommendations are based on available scientific data and the authors’ collective expert opinion. ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Filetti AO22 ESMO GL thyr.pdf
Accesso riservato
Dimensione
1.18 MB
Formato
Adobe PDF
|
1.18 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
